Fetal cardiac evaluation in HIV-positive women under HAART therapy in a Romanian hospital
- PMID: 33936263
- PMCID: PMC8082575
- DOI: 10.3892/etm.2021.10038
Fetal cardiac evaluation in HIV-positive women under HAART therapy in a Romanian hospital
Abstract
Human immunodeficiency virus (HIV) is an RNA (ribonucleic acid) virus that causes acquired immunodeficiency syndrome (AIDS). This disease has a major socioeconomical impact. The aim of the present study was to assess the fetal heart structure and function in HIV-positive pregnant women on highly active antiretroviral therapy (HAART). This is a prospective study conducted between January, 2018 and December, 2019. The hearts of fetuses from 14 HIV-positive pregnant women on HAART were assessed. Statistically significant sex-related cardiac changes in HIV-exposed uninfected fetuses of pregnant women on HAART were found. A narrow aorta was detected in female fetuses and a smaller left ventricular transverse diameter in male fetuses. Overall, the myocardial performance index remained unaltered. The impact of antiretroviral therapy on fetal heart seems to be sex-related. Accurate and complete information about the risks and benefits of antiretroviral treatment and management strategies to improve fetal outcomes may also ensure better compliance of the mothers to this treatment.
Keywords: AIDS; HIV; antiretroviral therapy; fetal heart; pregnancy.
Copyright: © Ursache et al.
Conflict of interest statement
The authors declare that they have no competing interests.
References
-
- Dorobăţ CM, Haliciu AM, Bejan C. Interdisciplinary correlations regarding the clinical and paraclinical evaluations in HIV-positive pregnant women. Rev Med Chir Soc Med Nat Iasi. 2014;3:749–752. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources